Matches in Nanopublications for { ?s ?p "[Our results implied that NAM might be a potential therapeutic agent for human pancreatic cancer treatment through downregulating SIRT1, K-Ras and P-Akt expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP856024.RAtWYYvCHTJEk5sWFBzhix5Vm9RW9wd4-ZlzpTj7EDRis130_assertion description "[Our results implied that NAM might be a potential therapeutic agent for human pancreatic cancer treatment through downregulating SIRT1, K-Ras and P-Akt expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP856024.RAtWYYvCHTJEk5sWFBzhix5Vm9RW9wd4-ZlzpTj7EDRis130_provenance.
- NP872172.RAXsbWWu9ILciluoHlOy21nAUxwd7NmFqaK4SqrvQASHg130_assertion description "[Our results implied that NAM might be a potential therapeutic agent for human pancreatic cancer treatment through downregulating SIRT1, K-Ras and P-Akt expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872172.RAXsbWWu9ILciluoHlOy21nAUxwd7NmFqaK4SqrvQASHg130_provenance.
- NP872202.RATQebJXEHmGcdGCd48NO01yxPkozK7WPzRDMySpqJ7y4130_assertion description "[Our results implied that NAM might be a potential therapeutic agent for human pancreatic cancer treatment through downregulating SIRT1, K-Ras and P-Akt expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP872202.RATQebJXEHmGcdGCd48NO01yxPkozK7WPzRDMySpqJ7y4130_provenance.
- NP1066919.RA1pqcjn8SjD52FE0efrGW0T4sDS2IxzHirFFB_6IuOoY130_assertion description "[Our results implied that NAM might be a potential therapeutic agent for human pancreatic cancer treatment through downregulating SIRT1, K-Ras and P-Akt expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1066919.RA1pqcjn8SjD52FE0efrGW0T4sDS2IxzHirFFB_6IuOoY130_provenance.
- NP1066921.RA-kmg8mHRemL_x9U6ukdCEc0yQAw2_8kwypT6KPM6Zcg130_assertion description "[Our results implied that NAM might be a potential therapeutic agent for human pancreatic cancer treatment through downregulating SIRT1, K-Ras and P-Akt expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1066921.RA-kmg8mHRemL_x9U6ukdCEc0yQAw2_8kwypT6KPM6Zcg130_provenance.